Aceso Life Science Group Limited (HKG:0474)

Aceso Life Science Group Cash Flow Statement

Financials in millions HKD. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	-895	-462	-264	-370
Depreciation & Amortization	43	50	52	68
Loss (Gain) From Sale of Investments	171	316	46	501
Asset Writedown & Restructuring Costs	612	89	6	-89
Loss (Gain) on Equity Investments	94	325	209	74
Stock-Based Compensation	-	-	3	7
Change in Accounts Payable	-2	-7	7	2
Change in Trading Asset Securities	10	29	24	-52
Change in Other Net Operating Assets	-19	-102	74	255
Other Operating Activities	-10	-277	45	-88
Operating Cash Flow	17	-37	214	316
Operating Cash Flow Growth	-	-	-32.28%	76.54%

Investing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-2	-11	-24	-57
Sale of Property, Plant & Equipment	17	-	8	14
Divestitures	-	-	1	-
Investment in Securities	-60	30	-86	4
Other Investing Activities	382	56	-11	-402
Investing Cash Flow	337	75	-112	-441

Financing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	-	1	-	24
Long-Term Debt Issued	-	693	481	882
Total Debt Issued	-	694	481	906
Short-Term Debt Repaid	-	-	-20	-12
Long-Term Debt Repaid	-486	-855	-593	-588
Total Debt Repaid	-486	-855	-613	-600
Net Debt Issued (Repaid)	-486	-161	-132	306
Repurchase of Common Stock	-13	-	-9	-5
Other Financing Activities	-88	278	43	-175
Financing Cash Flow	-587	117	-98	126

Net Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	15	8	-12	-4
Net Cash Flow	-218	163	-8	-3

Free Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	15	-48	190	259
Free Cash Flow Growth	-	-	-26.64%	57.93%
Free Cash Flow Margin	-	-436.36%	91.79%	152.35%
Free Cash Flow Per Share	0.00	-0.01	0.03	0.04

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	93	142	113	152
Cash Income Tax Paid	5	10	-	3

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 19, 2026

Data Sources Report a data error